Home > Healthcare > Medical Devices > Diagnostic Devices > Respiratory Disease Testing Market

Respiratory Disease Testing Market Share

Report ID: GMI1871
Published Date: Apr 2023
Report Format: PDF

Download Free Sample

Respiratory Disease Testing Market Share

Some of the leading players in the respiratory disease testing market include:

Abbott
Becton
Dickinson and Company
Koninklijke Philips N.V
ResMed
VYAIRE MEDICAL INC
Fischer & Paykel, Medtronic
BioMerieux SA
CAREstream Medical Ltd
Thermo Fischer Scientific
Cosmed
Seegene Inc
SDI Diagnostics
Siemens Healthineers.

Authors: Mariam Faizullabhoy

Frequently Asked Questions (FAQ) :

Global market for respiratory disease testing reached USD 14 billion in 2022 and will exhibit 6.5% CAGR from 2023-2032 due to the growing number of government-led initiatives.

In vitro diagnostics tests will showcase more than 6% CAGR from 2023-2032 owing to their multiple advantages in the diagnosis and treatment of respiratory conditions.

The respiratory disease testing market in North America will record 6.4% CAGR from 2023-2032 on account of the strong presence of well-developed healthcare infrastructure in the region.

Abbott, Becton, Dickinson, and Company, Koninklijke Philips N.V., ResMed, VYAIRE MEDICAL, INC., Fischer & Paykel, Medtronic, BioMerieux SA, Cosmed, Seegene Inc., SDI Diagnostics, and Siemens Healthineers are the major market participants.